This report studies the global Healthcare Nanotechnology market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Healthcare Nanotechnology market by companies, region, type and end-use industry.
Nanotechnology — the science of the extremely small — holds enormous potential for healthcare, from delivering drugs more effectively, diagnosing diseases more rapidly and sensitively, and delivering vaccines via aerosols and patches.Nanotechnology is the science of materials at the molecular or subatomic level. It involves manipulation of particles smaller than 100 nanometres (one nanometre is one-billionth of a metre) and the technology involves developing materials or devices within that size — invisible to the human eye and often many hundred times thinner than the width of human hair. The physics and chemistry of materials are radically different when reduced to the nanoscale; they have different strengths, conductivity and reactivity, and exploiting this could revolutionise medicine.
First of all，major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, it has drawback such as high costs of Nanotechnology-Based Medical Devices and it is money-consuming. Second, the United States dominates the market, and is expected to increase over the forecast period. In addition, Asia Pacific region is expected to witness highest growth rate over the forecast period owing to rapid population growth.
In 2020, the global Healthcare Nanotechnology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global top players, covered
Abbott Laboratories
Teva Pharmaceuticals Industries
Johnson & Johnson
Pfizer
Merck
NanosphereInc
GE Healthcare Celgene Corporation
CombiMatrix Corporation
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Neurology
Cardiovascular
Oncology
Anti-inflammatory
Anti-infective
Market segment by Application, split into
Drug Delivery System
Molecular Diagnostics
Clinical Oncology
Clinical Neurology
The study objectives of this report are:
To study and forecast the market size of Healthcare Nanotechnology in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Healthcare Nanotechnology are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Healthcare Nanotechnology Manufacturers
Healthcare Nanotechnology Distributors/Traders/Wholesalers
Healthcare Nanotechnology Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, LBIesearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Healthcare Nanotechnology market, by end-use.
Detailed analysis and profiles of additional market players.
Nanotechnology — the science of the extremely small — holds enormous potential for healthcare, from delivering drugs more effectively, diagnosing diseases more rapidly and sensitively, and delivering vaccines via aerosols and patches.Nanotechnology is the science of materials at the molecular or subatomic level. It involves manipulation of particles smaller than 100 nanometres (one nanometre is one-billionth of a metre) and the technology involves developing materials or devices within that size — invisible to the human eye and often many hundred times thinner than the width of human hair. The physics and chemistry of materials are radically different when reduced to the nanoscale; they have different strengths, conductivity and reactivity, and exploiting this could revolutionise medicine.
First of all，major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, it has drawback such as high costs of Nanotechnology-Based Medical Devices and it is money-consuming. Second, the United States dominates the market, and is expected to increase over the forecast period. In addition, Asia Pacific region is expected to witness highest growth rate over the forecast period owing to rapid population growth.
In 2020, the global Healthcare Nanotechnology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global top players, covered
Abbott Laboratories
Teva Pharmaceuticals Industries
Johnson & Johnson
Pfizer
Merck
NanosphereInc
GE Healthcare Celgene Corporation
CombiMatrix Corporation
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Neurology
Cardiovascular
Oncology
Anti-inflammatory
Anti-infective
Market segment by Application, split into
Drug Delivery System
Molecular Diagnostics
Clinical Oncology
Clinical Neurology
The study objectives of this report are:
To study and forecast the market size of Healthcare Nanotechnology in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Healthcare Nanotechnology are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Healthcare Nanotechnology Manufacturers
Healthcare Nanotechnology Distributors/Traders/Wholesalers
Healthcare Nanotechnology Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, LBIesearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Healthcare Nanotechnology market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Healthcare Nanotechnology Market Size, Status and Forecast 2027
1 Industry Overview of Healthcare Nanotechnology
1.1 Healthcare Nanotechnology Market Overview
1.1.1 Healthcare Nanotechnology Product Scope
1.1.2 Market Status and Outlook
1.2 Global Healthcare Nanotechnology Market Size and Analysis by Regions (2016-2021)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Healthcare Nanotechnology Market by Type
1.3.1 Neurology
1.3.2 Cardiovascular
1.3.3 Oncology
1.3.4 Anti-inflammatory
1.3.5 Anti-infective
1.4 Healthcare Nanotechnology Market by End Users/Application
1.4.1 Drug Delivery System
1.4.2 Molecular Diagnostics
1.4.3 Clinical Oncology
1.4.4 Clinical Neurology
2 Global Healthcare Nanotechnology Competition Analysis by Players
2.1 Healthcare Nanotechnology Market Size (Value) by Players (2016-2021)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.2 Teva Pharmaceuticals Industries
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.3 Johnson & Johnson
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.4 Pfizer
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.5 Merck
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.6 NanosphereInc
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.7 GE Healthcare Celgene Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.8 CombiMatrix Corporation
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
4 Global Healthcare Nanotechnology Market Size by Type and Application (2016-2021)
4.1 Global Healthcare Nanotechnology Market Size by Type (2016-2021)
4.2 Global Healthcare Nanotechnology Market Size by Application (2016-2021)
4.3 Potential Application of Healthcare Nanotechnology in Future
4.4 Top Consumer/End Users of Healthcare Nanotechnology
5 United States Healthcare Nanotechnology Development Status and Outlook
5.1 United States Healthcare Nanotechnology Market Size (2016-2021)
5.2 United States Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
5.3 United States Healthcare Nanotechnology Market Size by Application (2016-2021)
6 Europe Healthcare Nanotechnology Development Status and Outlook
6.1 Europe Healthcare Nanotechnology Market Size (2016-2021)
6.2 Europe Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
6.3 Europe Healthcare Nanotechnology Market Size by Application (2016-2021)
7 China Healthcare Nanotechnology Development Status and Outlook
7.1 China Healthcare Nanotechnology Market Size (2016-2021)
7.2 China Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
7.3 China Healthcare Nanotechnology Market Size by Application (2016-2021)
8 Japan Healthcare Nanotechnology Development Status and Outlook
8.1 Japan Healthcare Nanotechnology Market Size (2016-2021)
8.2 Japan Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
8.3 Japan Healthcare Nanotechnology Market Size by Application (2016-2021)
9 Southeast Asia Healthcare Nanotechnology Development Status and Outlook
9.1 Southeast Asia Healthcare Nanotechnology Market Size (2016-2021)
9.2 Southeast Asia Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
9.3 Southeast Asia Healthcare Nanotechnology Market Size by Application (2016-2021)
10 India Healthcare Nanotechnology Development Status and Outlook
10.1 India Healthcare Nanotechnology Market Size (2016-2021)
10.2 India Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
10.3 India Healthcare Nanotechnology Market Size by Application (2016-2021)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Healthcare Nanotechnology Market Size (Value) by Regions (2021-2027)
11.1.1 United States Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.2 Europe Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.3 China Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.4 Japan Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.5 Southeast Asia Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.6 India Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.2 Global Healthcare Nanotechnology Market Size (Value) by Type (2021-2027)
11.3 Global Healthcare Nanotechnology Market Size by Application (2021-2027)
12 Healthcare Nanotechnology Market Dynamics
12.1 Healthcare Nanotechnology Market Opportunities
12.2 Healthcare Nanotechnology Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Healthcare Nanotechnology Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Healthcare Nanotechnology Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Global Healthcare Nanotechnology Market Size, Status and Forecast 2027
1 Industry Overview of Healthcare Nanotechnology
1.1 Healthcare Nanotechnology Market Overview
1.1.1 Healthcare Nanotechnology Product Scope
1.1.2 Market Status and Outlook
1.2 Global Healthcare Nanotechnology Market Size and Analysis by Regions (2016-2021)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Healthcare Nanotechnology Market by Type
1.3.1 Neurology
1.3.2 Cardiovascular
1.3.3 Oncology
1.3.4 Anti-inflammatory
1.3.5 Anti-infective
1.4 Healthcare Nanotechnology Market by End Users/Application
1.4.1 Drug Delivery System
1.4.2 Molecular Diagnostics
1.4.3 Clinical Oncology
1.4.4 Clinical Neurology
2 Global Healthcare Nanotechnology Competition Analysis by Players
2.1 Healthcare Nanotechnology Market Size (Value) by Players (2016-2021)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.2 Teva Pharmaceuticals Industries
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.3 Johnson & Johnson
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.4 Pfizer
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.5 Merck
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.6 NanosphereInc
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.7 GE Healthcare Celgene Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
3.8 CombiMatrix Corporation
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Healthcare Nanotechnology Revenue (Million USD) (2016-2021)
4 Global Healthcare Nanotechnology Market Size by Type and Application (2016-2021)
4.1 Global Healthcare Nanotechnology Market Size by Type (2016-2021)
4.2 Global Healthcare Nanotechnology Market Size by Application (2016-2021)
4.3 Potential Application of Healthcare Nanotechnology in Future
4.4 Top Consumer/End Users of Healthcare Nanotechnology
5 United States Healthcare Nanotechnology Development Status and Outlook
5.1 United States Healthcare Nanotechnology Market Size (2016-2021)
5.2 United States Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
5.3 United States Healthcare Nanotechnology Market Size by Application (2016-2021)
6 Europe Healthcare Nanotechnology Development Status and Outlook
6.1 Europe Healthcare Nanotechnology Market Size (2016-2021)
6.2 Europe Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
6.3 Europe Healthcare Nanotechnology Market Size by Application (2016-2021)
7 China Healthcare Nanotechnology Development Status and Outlook
7.1 China Healthcare Nanotechnology Market Size (2016-2021)
7.2 China Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
7.3 China Healthcare Nanotechnology Market Size by Application (2016-2021)
8 Japan Healthcare Nanotechnology Development Status and Outlook
8.1 Japan Healthcare Nanotechnology Market Size (2016-2021)
8.2 Japan Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
8.3 Japan Healthcare Nanotechnology Market Size by Application (2016-2021)
9 Southeast Asia Healthcare Nanotechnology Development Status and Outlook
9.1 Southeast Asia Healthcare Nanotechnology Market Size (2016-2021)
9.2 Southeast Asia Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
9.3 Southeast Asia Healthcare Nanotechnology Market Size by Application (2016-2021)
10 India Healthcare Nanotechnology Development Status and Outlook
10.1 India Healthcare Nanotechnology Market Size (2016-2021)
10.2 India Healthcare Nanotechnology Market Size and Market Share by Players (2016-2021)
10.3 India Healthcare Nanotechnology Market Size by Application (2016-2021)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Healthcare Nanotechnology Market Size (Value) by Regions (2021-2027)
11.1.1 United States Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.2 Europe Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.3 China Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.4 Japan Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.5 Southeast Asia Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.1.6 India Healthcare Nanotechnology Revenue and Growth Rate (2021-2027)
11.2 Global Healthcare Nanotechnology Market Size (Value) by Type (2021-2027)
11.3 Global Healthcare Nanotechnology Market Size by Application (2021-2027)
12 Healthcare Nanotechnology Market Dynamics
12.1 Healthcare Nanotechnology Market Opportunities
12.2 Healthcare Nanotechnology Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Healthcare Nanotechnology Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Healthcare Nanotechnology Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
